Araris Biotech AG
Araris Biotech AG is a Healthcare & Life Sciences startup based in Switzerland, most recent round Series A, 2 tracked investors.
About Araris Biotech AG
Araris Biotech AG is a startup founded in 2019 based in Switzerland. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Araris Biotech AG is a Swiss biotech spin-off from the Paul Scherrer Institute and ETH Zurich that develops proprietary peptide linker technology for antibody-drug conjugates (ADCs). Its platform enables stable, homogeneous attachment of cytotoxic payloads to antibodies to create targeted cancer therapies.
Explore Araris Biotech AG's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.